Insider Holders & Insider Ownership - CASI Pharmaceuticals Inc. (CASI)

List of insiders holdings for CASI Pharmaceuticals Inc.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
# Insider Holder Name Report
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
1 CELGENE CORP
10% Owner
2006-03-10 20:19:48 24,614,864
0
24,614,864 Form 13D
2 Wealth Strategy Holding Ltd
10% Owner
2020-02-19 16:05:17 10,684,625
0
10,684,625 Form 13G
3 Li Dapeng
10% Owner
2019-02-06 16:06:47 9,364,130
0
9,364,130 Form 13G
4 SPECTRUM PHARMACEUTICALS INC
Spectrum Pharmaceuticals Cayman L.P.
10% Owner
2021-04-30 16:11:30 6,886,956
0
6,886,956 Form 13D
5 He Wei-Wu
Chairman and CEO
10% Owner
2022-06-21 16:26:09 2,761,349
0
2,761,349 Form 13D
6 IDG-Accel China Growth Fund III L.P.
IDG-Accel China III Investors L.P.
IDG-Accel China Growth Fund III Associates L.P.
IDG-Accel China Growth Fund GP III Associates Ltd.
Ho Chi Sing
Zhou Quan
10% Owner
2023-02-21 07:33:47 1,053,638
0
1,053,638 Form 13D
7 SPARKLE BYTE LTD
SNOW MOON LTD
TIANJIN JINGRAN MANAGEMENT CENTER (LIMITED PARTNERSHIP)
HE XIE AI QI INVESTMENT MANAGEMENT (BEIJING) CO. LTD.
Li Jianguang
Lin Dongliang
Yang Fei
Zhang Suyang
Shong Hugo
10% Owner
2024-02-20 11:40:06 1,019,852
0
1,019,852 Form 13D
8 SPARKLE BYTE LTD
SNOW MOON LTD
TIANJIN JINGRAN MANAGEMENT CENTER (LIMITED PARTNERSHIP)
HE XIE AI QI INVESTMENT MANAGEMENT (BEIJING) CO. LTD.
Li Jianguang
Lin Dongliang
Yang Fei
Shong Hugo
10% Owner
2024-02-20 11:40:06 1,019,852
0
1,019,852 Form 13D
9 Xu Weihao
Chief Financial Officer
2020-12-18 16:05:26 800,000
10,000
810,000 Form 4
10 Zhang Larry
President
2021-07-26 18:08:05 800,000
0
800,000 Form 4
11 Chi George
Chief Financial Officer
2018-10-02 19:20:33 400,000
0
400,000 Form 4
12 Wu Yue Alexander
Director
2022-05-26 16:13:08 388,387
0
388,387 Form 4
13 Salisbury Franklin Cary jr
Director
2022-05-26 16:12:18 388,387
0
388,387 Form 4
14 Zhou Quan
Director
2022-05-26 16:24:15 380,645
0
380,645 Form 4
15 Huang James
Director
2022-09-08 18:51:39 191
371,517
371,708 Form 4
16 SHROTRIYA RAJESH C MD
Director
2022-05-26 16:11:29 345,806
0
345,806 Form 4
17 Bliss Thomas H Jr
SVP, Bus. & Corp. Development
2008-06-19 12:03:56 300,000
0
300,000 Form 4
18 Burns James S
President and CEO
2008-09-17 10:20:14 185,300
0
185,300 Form 4
19 Wehmeir-Davis Kathy
Principal Accounting Officer
2009-01-29 14:39:06 140,000
0
140,000 Form 4
20 CAPE RONALD
Director
2007-06-18 15:12:04 95,533
0
95,533 Form 4
21 Hu Cynthia W.
COO, Gen Counsel & Secretary
2019-01-31 19:19:27 75,000
0
75,000 Form 4
22 KNIGHT PETER S
Director
2010-01-28 15:54:37 55,000
0
55,000 Form 4
23 Ren Ken Keyong
Director
2019-06-21 17:01:22 51,538
0
51,538 Form 4
24 RANDALL MARK C M
Director
2012-03-14 16:42:40 50,000
0
50,000 Form 4
25 TARNOW MICHAEL M
Director
2012-01-25 18:15:04 50,000
0
50,000 Form 4
26 Corrado Marc
VP Corporate Development
2006-12-20 12:47:24 50,000
0
50,000 Form 4
27 JOHNSON JAMES D
Secretary of the Board
2003-10-23 09:38:35 40,000
0
40,000 Form 4
28 BUSH DWIGHT L
Director
2013-05-31 18:47:00 37,500
0
37,500 Form 4
29 HUNTER CEVERA JENNIE
Director
2013-05-31 18:33:56 37,500
0
37,500 Form 4
30 Wu Alex
Director
2018-07-03 15:36:41 35,000
0
35,000 Form 4
31 Mak Tak W.
Director
2016-03-04 16:48:01 35,000
0
35,000 Form 4
32 Sidor Carolyn F
V.P. and Chief Medical Officer
2011-01-12 16:19:55 30,000
0
30,000 Form 4
33 CAMPBELL NEIL J
President and COO
2004-05-07 12:52:14 25,000
0
25,000 Form 4
34 BROOKS DONALD S
Director
2012-01-25 18:22:26 25,000
0
25,000 Form 4
35 Bair Kenneth Walter
SVP, Research and Development
2008-03-25 12:14:17 20,000
0
20,000 Form 4
36 Ren Ken
CEO and Director
2016-01-21 14:44:20 15,000
0
15,000 Form 4
37 Bray Mark R
Vice President, Research
2011-01-12 16:13:17 10,000
0
10,000 Form 4
38 SAGLIO DANE R
Chief Financial Officer
2008-03-24 07:24:31 7,300
0
7,300 Form 4
39 Zukiwski Alexander A
EVP and Chief Medical Officer
2022-09-09 16:01:37 3,000
0
3,000 Form 4
40 KLEIN UDO
Senior Vice President of R&D
2004-09-07 11:55:56 1,800
0
1,800 Form 4
41 CAPITELLI SARA B
VP Fin & Principal Account Off
2018-07-13 17:09:19 0
0
0 Form 4